Blood platelets mediate hemostasis as well as diverse pathologic processes, including thrombosis and inflammation, and thrombocytopenia is a frequent, dose-limiting complication of cancer chemotherapy. The importance of platelets in diseases that are common in the United States is thus well recognized. This makes it necessary to understand how terminally differentiated megakaryocytes (MKs) fragment and release blood platelets. Despite the discovery of thrombopoietin (Tpo) and its signal transduction pathways in MKs, the cellular and molecular basis of terminal MK maturation and platelet release remain unknown. Mice lacking the erythro-megakaryocytic transcription factor NF-E2 have severe, usually lethal, thrombocytopenia resulting from a late arrest in MK cytoplasmic differentiation. Hence, they constitute a powerful and unique model to study thrombocytopoiesis, and are an important tool in the P.I.'s long-term goal of defining molecular aspects of platelet production. MKs deficient in NF-E2 have a cell-autonomous defect and fail to produce proplatelets, the precursors of blood platelets, in culture. However, the transcriptional targets of NF-E2 and the relevant biochemical pathways of terminal MK differentiation are not known. Initial efforts to identify genes that fail to be expressed in the absence of NF-E2 have led to a MK-and platelet-specific beta tubulin isoform (beta1) that normally appears late in MK differentiation, localizes to proplatelets and platelet marginal bands, and possibly mediates the cytoplasmic reorganization that accompanies platelet release. Beta1 tubulin expression is completely lost in the absence of NF-E2 function. Preliminary data thus strongly suggest that loss of beta1 tubulin expression in MKs might explain in part why blood platelets are not produced in the absence of NF-E2.
The Specific Aims of this proposal include determining whether the absence of beta1 tubulin in NF-E2-deficient cells reflects direct regulation by this transcription factor, and whether restoring beta1 tubulin expression in the defective MKs is sufficient to rescue some or all aspects of thrombocytopoiesis. Further, we propose to use gene targeting in mice to test the essential roles of beta1 tubulin in vivo, independent of its putative relation to NF-E2. Finally, we propose to use a previously successful mRNA subtraction strategy to identify and characterize additional molecular targets of NF-E2 that may participate in platelet biogenesis. The results of these studies should substantially improve the current understanding of how MKs produce blood platelets.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dana-Farber Cancer Institute
United States
Zip Code
Zang, Chongzhi; Luyten, Annouck; Chen, Justina et al. (2016) NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes. Sci Rep 6:30255
Luyten, Annouck; Zang, Chongzhi; Liu, X Shirley et al. (2014) Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells. Genes Dev 28:1827-39
Verzi, Michael P; Hatzis, Pantelis; Sulahian, Rita et al. (2010) TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc Natl Acad Sci U S A 107:15157-62
Verzi, Michael P; Shin, Hyunjin; He, H Hansen et al. (2010) Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev Cell 19:713-26
Horst, David; Gu, Xuesong; Bhasin, Manoj et al. (2010) Requirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum. J Biol Chem 285:35047-55
Chen, Z; Shivdasani, R A (2009) Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders. J Thromb Haemost 7 Suppl 1:272-6
Schulze, Harald; Dose, Marei; Korpal, Manav et al. (2008) RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules. J Biol Chem 283:14109-19
Junt, Tobias; Schulze, Harald; Chen, Zhao et al. (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317:1767-70
Chen, Zhao; Hu, Michael; Shivdasani, Ramesh A (2007) Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. Blood 109:1451-9
Chen, Zhao; Naveiras, Olaia; Balduini, Alessandra et al. (2007) The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood 110:171-9

Showing the most recent 10 out of 21 publications